Novel variants at KCTD10, MVK, and MMAB genes interact with dietary carbohydrates to modulate HDL-cholesterol concentrations in the Genetics of Lipid Lowering Drugs and Diet Network Study
Junyent et al.
Am. J. Clin. Nutr. 2009;90:686-694.
ABSTRACT
| FULL TEXT
Changes in Lipid Profile Between Flare and Remission of Patients with Systemic Lupus Erythematosus: A Prospective Study
URQUIZU-PADILLA et al.
The Journal of Rheumatology 2009;36:1639-1645.
ABSTRACT
| FULL TEXT
Poor Glycemic Control Is an Independent Risk Factor for Low HDL Cholesterol in Patients With Type 2 Diabetes
Gatti et al.
Diabetes Care 2009;32:1550-1552.
ABSTRACT
| FULL TEXT
Hemoglobin and Its Scavenger Protein Haptoglobin Associate with ApoA-1-containing Particles and Influence the Inflammatory Properties and Function of High Density Lipoprotein
Watanabe et al.
J. Biol. Chem. 2009;284:18292-18301.
ABSTRACT
| FULL TEXT
Diagnosis and treatment of acquired coronary artery disease in adults
Wilson
Postgrad. Med. J. 2009;85:364-365.
ABSTRACT
| FULL TEXT
Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients
Popa et al.
Ann Rheum Dis 2009;68:868-872.
ABSTRACT
| FULL TEXT
Scavenger Receptor Class B Type I Protein as an Independent Predictor of High-Density Lipoprotein Cholesterol Levels in Subjects with Hyperalphalipoproteinemia
West et al.
J. Clin. Endocrinol. Metab. 2009;94:1451-1457.
ABSTRACT
| FULL TEXT
Targeted inactivation of endothelial lipase attenuates lung allergic inflammation through raising plasma HDL level and inhibiting eosinophil infiltration
Otera et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 2009;296:L594-L602.
ABSTRACT
| FULL TEXT
Long-term Benefit of High-Density Lipoprotein Cholesterol-Raising Therapy With Bezafibrate: 16-Year Mortality Follow-up of the Bezafibrate Infarction Prevention Trial
Goldenberg et al.
Arch Intern Med 2009;169:508-514.
ABSTRACT
| FULL TEXT
Identification of three loci affecting HDL-cholesterol levels in a screen for chemically induced recessive mutations in mice
Juan et al.
J. Lipid Res. 2009;50:534-545.
ABSTRACT
| FULL TEXT
The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study
Junyent et al.
J. Lipid Res. 2009;50:565-573.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response
Murphy et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:2071-2077.
ABSTRACT
| FULL TEXT
Apolipoprotein A-I Tryptophan Substitution Leads to Resistance to Myeloperoxidase-Mediated Loss of Function
Peng et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:2063-2070.
ABSTRACT
| FULL TEXT
The 15-Lipoxygenase-Modified High Density Lipoproteins 3 Fail to Inhibit the TNF-{alpha}-Induced Inflammatory Response in Human Endothelial Cells
Pirillo et al.
J. Immunol. 2008;181:2821-2830.
ABSTRACT
| FULL TEXT
Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.
deGoma et al.
J Am Coll Cardiol 2008;51:2199-2211.
ABSTRACT
| FULL TEXT
The Specific Amino Acid Sequence between Helices 7 and 8 Influences the Binding Specificity of Human Apolipoprotein A-I for High Density Lipoprotein (HDL) Subclasses: A POTENTIAL FOR HDL PREFERENTIAL GENERATION
Carnemolla et al.
J. Biol. Chem. 2008;283:15779-15788.
ABSTRACT
| FULL TEXT
The -250G>A Promoter Variant in Hepatic Lipase Associates with Elevated Fasting Serum High-Density Lipoprotein Cholesterol Modulated by Interaction with Physical Activity in a Study of 16,156 Danish Subjects
Grarup et al.
J. Clin. Endocrinol. Metab. 2008;93:2294-2299.
ABSTRACT
| FULL TEXT
Central Nervous System Neuropeptide Y Signaling Modulates VLDL Triglyceride Secretion
Stafford et al.
Diabetes 2008;57:1482-1490.
ABSTRACT
| FULL TEXT
Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus Conference Report From the American Diabetes Association and the American College of Cardiology Foundation
Brunzell et al.
J Am Coll Cardiol 2008;51:1512-1524.
FULL TEXT
Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation
Brunzell et al.
Diabetes Care 2008;31:811-822.
FULL TEXT
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
van der Steeg et al.
J Am Coll Cardiol 2008;51:634-642.
ABSTRACT
| FULL TEXT
Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.
deGoma et al.
J Am Coll Cardiol 2008;51:49-55.
ABSTRACT
| FULL TEXT
Increased Oxidative Stress in Scavenger Receptor BI Knockout Mice With Dysfunctional HDL
Van Eck et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:2413-2419.
ABSTRACT
| FULL TEXT
High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1
Terasaka et al.
Proc. Natl. Acad. Sci. USA 2007;104:15093-15098.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein as a Therapeutic Target: A Systematic Review
Singh et al.
JAMA 2007;298:786-798.
ABSTRACT
| FULL TEXT
Differential Association of Hemoglobin with Proinflammatory High Density Lipoproteins in Atherogenic/Hyperlipidemic Mice: A NOVEL BIOMARKER OF ATHEROSCLEROSIS
Watanabe et al.
J. Biol. Chem. 2007;282:23698-23707.
ABSTRACT
| FULL TEXT
ATP-Binding Cassette Transporter A1 Gene Transcription Is Downregulated by Activator Protein 2{alpha}: Doxazosin Inhibits Activator Protein 2{alpha} and Increases High-Density Lipoprotein Biogenesis Independent of {alpha}1-Adrenoceptor Blockade
Iwamoto et al.
Circ. Res. 2007;101:156-165.
ABSTRACT
| FULL TEXT
Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis
Peters et al.
Ann Rheum Dis 2007;66:958-961.
ABSTRACT
| FULL TEXT
In Vivo Evidence for a Role of Adipose Tissue SR-BI in the Nutritional and Hormonal Regulation of Adiposity and Cholesterol Homeostasis
Yvan-Charvet et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:1340-1345.
ABSTRACT
| FULL TEXT
ROS and NF-{kappa}B but not LXR mediate IL-1beta signaling for the downregulation of ATP-binding cassette transporter A1
Chen et al.
Am. J. Physiol. Cell Physiol. 2007;292:C1493-C1501.
ABSTRACT
| FULL TEXT
Ratio determination of plasma wild-type and L159R apoA-I using mass spectrometry: tools for studying apoA-IFin
Owen et al.
J. Lipid Res. 2007;48:226-234.
ABSTRACT
| FULL TEXT
Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors
Roberts et al.
J. Appl. Physiol. 2006;101:1727-1732.
ABSTRACT
| FULL TEXT
Homocysteine and Cardiovascular Disease: Is HDL the Link?
Barter and Rye
Circ. Res. 2006;99:565-566.
FULL TEXT
Vascular Biomarkers and Surrogates in Cardiovascular Disease
Tardif et al.
Circulation 2006;113:2936-2942.
ABSTRACT
| FULL TEXT
Impact on cardiovascular events of increasing high density lipoprotein cholesterol with and without lipid lowering drugs
Wei et al.
Heart 2006;92:746-751.
ABSTRACT
| FULL TEXT
LXR-Induced Redistribution of ABCG1 to Plasma Membrane in Macrophages Enhances Cholesterol Mass Efflux to HDL
Wang et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:1310-1316.
ABSTRACT
| FULL TEXT
Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors
Roberts et al.
J. Appl. Physiol. 2006;100:1657-1665.
ABSTRACT
| FULL TEXT
High-Density Lipoproteins Enhance Progenitor-Mediated Endothelium Repair in Mice
Tso et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:1144-1149.
ABSTRACT
| FULL TEXT
Effect of Ezetimibe on the In Vivo Kinetics of ApoB-48 and ApoB-100 in Men With Primary Hypercholesterolemia
Tremblay et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:1101-1106.
ABSTRACT
| FULL TEXT
Management of Dyslipidemia in Special Populations
Tovar and Schering
Journal of Pharmacy Practice 2006;19:63-78.
ABSTRACT
Association between Carbohydrate Intake and Serum Lipids.
Ma et al.
J. Am. Coll. Nutr. 2006;25:155-163.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein Hydrolysis by Endothelial Lipase Activates PPAR{alpha}: A Candidate Mechanism for High-Density Lipoprotein-Mediated Repression of Leukocyte Adhesion
Ahmed et al.
Circ. Res. 2006;98:490-498.
ABSTRACT
| FULL TEXT
HDL Becoming Important Piece of CHD Puzzle
Ullman
DOC News 2006;3:9-9.
FULL TEXT
Perspectives on Dyslipidemia and Coronary Heart Disease in Women
Bittner
J Am Coll Cardiol 2005;46:1628-1635.
ABSTRACT
| FULL TEXT
ABCG1 Redistributes Cell Cholesterol to Domains Removable by High Density Lipoprotein but Not by Lipid-depleted Apolipoproteins
Vaughan and Oram
J. Biol. Chem. 2005;280:30150-30157.
ABSTRACT
| FULL TEXT
The frequency of high/moderate lipoprotein risk factor for coronary artery disease is significant in juvenile-onset systemic lupus erythematosus
Hayata et al.
Lupus 2005;14:613-617.
ABSTRACT
The role of HDL-cholesterol in preventing atherosclerotic disease
Barter
Eur Heart J Suppl 2005;7:F4-F8.
ABSTRACT
| FULL TEXT
Raising HDL-cholesterol and lowering CHD risk: does intervention work?
Shepherd
Eur Heart J Suppl 2005;7:F15-F22.
ABSTRACT
| FULL TEXT
The realities of dyslipidaemia: what do the studies tell us?
Kastelein
Eur Heart J Suppl 2005;7:F27-F33.
ABSTRACT
| FULL TEXT
Maximizing coronary disease risk reduction using nicotinic acid combined with LDL-lowering therapy
Brown
Eur Heart J Suppl 2005;7:F34-F40.
ABSTRACT
| FULL TEXT
Beyond LDL-cholesterol reduction: the way ahead in managing dyslipidaemia
Chapman
Eur Heart J Suppl 2005;7:F56-F62.
ABSTRACT
| FULL TEXT
The Metabolic Syndrome: Requiescat in Pace
Reaven
Clin. Chem. 2005;51:931-938.
ABSTRACT
| FULL TEXT
ARBITER 2: targeting HDL to retard atherosclerosis progression: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2
Lee and Choudhury
British Journal of Diabetes & Vascular Disease 2005;5:78-80.
Reduced cholesterol absorption upon PPAR{delta} activation coincides with decreased intestinal expression of NPC1L1
van der Veen et al.
J. Lipid Res. 2005;46:526-534.
ABSTRACT
| FULL TEXT
A Prospective Study on the Prevalence of Metabolic Syndrome Among Healthy French Families: Two cardiovascular risk factors (HDL cholesterol and tumor necrosis factor-{alpha}) are revealed in the offspring of parents with metabolic syndrome
Maumus et al.
Diabetes Care 2005;28:675-682.
ABSTRACT
| FULL TEXT
Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study
Meisinger et al.
Eur Heart J 2005;26:271-278.
ABSTRACT
| FULL TEXT
Effects of exercise and diet on chronic disease
Roberts and Barnard
J. Appl. Physiol. 2005;98:3-30.
ABSTRACT
| FULL TEXT
The role of dyslipidaemia in coronary heart disease
Wierzbicki
British Journal of Diabetes & Vascular Disease 2005;5:S2-S6.
ABSTRACT
The realities of dyslipidaemia in metabolic syndrome and diabetes
Barter
British Journal of Diabetes & Vascular Disease 2005;5:S7-S11.
ABSTRACT
Modern intervention strategies for managing dyslipidaemia: the case for combination therapy
Drexel
British Journal of Diabetes & Vascular Disease 2005;5:S17-S23.
ABSTRACT
Serum Lipid Concentrations and Prevalence of Dyslipidemia in a Large Professional Population in Beijing
Li et al.
Clin. Chem. 2005;51:144-150.
ABSTRACT
| FULL TEXT
Active and low-active forms of serum phospholipid transfer protein in a normal Finnish population sample
Janis et al.
J. Lipid Res. 2004;45:2303-2309.
ABSTRACT
| FULL TEXT
Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity
Brehm et al.
Clin. Chem. 2004;50:2316-2322.
ABSTRACT
| FULL TEXT
Antiinflammatory Properties of HDL
Barter et al.
Circ. Res. 2004;95:764-772.
ABSTRACT
| FULL TEXT
The metabolic syndrome: one step forward, two steps back
Kim and Reaven
Diabetes and Vascular Disease Research 2004;1:68-75.
ABSTRACT
Familial Hypercholesterolemia and Coronary Heart Disease: A HuGE Association Review
Austin et al.
Am J Epidemiol 2004;160:421-429.
ABSTRACT
| FULL TEXT
Interrelationships Between Human Apolipoprotein A-I and Apolipoproteins B-48 and B-100 Kinetics Using Stable Isotopes
Welty et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:1703-1707.
ABSTRACT
| FULL TEXT
Is good cholesterol always good?
Thompson
BMJ 2004;329:471-472.
FULL TEXT
Should Angiotensin II Receptor Blockers and Statins Be Combined?
Nickenig
Circulation 2004;110:1013-1020.
FULL TEXT
Statins for the prevention of cerebrovascular disease: the rationale for robust intervention
Welch
Eur Heart J Suppl 2004;6:C34-C42.
ABSTRACT
| FULL TEXT
Carboxyl Ester Lipase Cofractionates with Scavenger Receptor BI in Hepatocyte Lipid Rafts and Enhances Selective Uptake and Hydrolysis of Cholesteryl Esters from HDL3
Camarota et al.
J. Biol. Chem. 2004;279:27599-27606.
ABSTRACT
| FULL TEXT
Low-Density Lipoprotein Particle Size and Its Regulatory Factors in School Children
Shimabukuro et al.
J. Clin. Endocrinol. Metab. 2004;89:2923-2927.
ABSTRACT
| FULL TEXT
Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
Navab et al.
J. Lipid Res. 2004;45:993-1007.
ABSTRACT
| FULL TEXT
What are the clinical manifestations of cardiovascular disease in diabetes? Ten year analysis from a clinic based population
Stephens et al.
British Journal of Diabetes & Vascular Disease 2004;4:190-194.
ABSTRACT
Influence of sex and diet on quantitative trait loci for HDL cholesterol levels in an SM/J by NZB/BlNJ intercross population
Korstanje et al.
J. Lipid Res. 2004;45:881-888.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein and Cardiovascular Risk
Toth
Circulation 2004;109:1809-1812.
FULL TEXT
Genetic Testing for Cardiovascular Disease Susceptibility: A Useful Clinical Management Tool or Possible Misinformation?
Humphries et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:628-636.
ABSTRACT
| FULL TEXT
Scavenger Receptor Class B Type I-mediated Cholesteryl Ester-selective Uptake and Efflux of Unesterified Cholesterol: INFLUENCE OF HIGH DENSITY LIPOPROTEIN SIZE AND STRUCTURE
Thuahnai et al.
J. Biol. Chem. 2004;279:12448-12455.
ABSTRACT
| FULL TEXT
Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2
Dhamrait et al.
Eur Heart J 2004;25:468-475.
ABSTRACT
| FULL TEXT
Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin Treatment
Ansell et al.
Circulation 2003;108:2751-2756.
ABSTRACT
| FULL TEXT
Apolipoprotein AI as Therapy for Atherosclerosis: Does the Future of Preventive Cardiology Include Weekly Injections of the HDL Protein?
Fazio and Linton
Mol. Interv. 2003;3:436-440.
ABSTRACT
| FULL TEXT
Inactivation of Macrophage Scavenger Receptor Class B Type I Promotes Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice
Zhang et al.
Circulation 2003;108:2258-2263.
ABSTRACT
| FULL TEXT
Effects of Apolipoprotein A-I on ATP-binding Cassette Transporter A1-mediated Efflux of Macrophage Phospholipid and Cholesterol: FORMATION OF NASCENT HIGH DENSITY LIPOPROTEIN PARTICLES
Liu et al.
J. Biol. Chem. 2003;278:42976-42984.
ABSTRACT
| FULL TEXT
Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism
Cohn et al.
J. Lipid Res. 2003;44:1976-1983.
ABSTRACT
| FULL TEXT
Apolipoprotein A-I Deficiency Results in Markedly Increased Atherosclerosis in Mice Lacking the LDL Receptor
Moore et al.
Arterioscler. Thromb. Vasc. Bio. 2003;23:1914-1920.
ABSTRACT
| FULL TEXT
Effects of Lipid Abnormalities on Arteriosclerosis and Hemostatic Markers in Patients under Hemodialysis
Kushiya et al.
CLIN APPL THROMB HEMOST 2003;9:203-210.
ABSTRACT
High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life
Ramet et al.
J Am Coll Cardiol 2003;41:2288-2297.
ABSTRACT
| FULL TEXT
Long-term tracking of cardiovascular risk factors among men and women in a large population-based health system: The Vorarlberg Health Monitoring & Promotion Programme
Ulmer et al.
Eur Heart J 2003;24:1004-1013.
ABSTRACT
| FULL TEXT
Association of I27L Polymorphism of Hepatocyte Nuclear Factor-1{alpha} Gene with High-Density Lipoprotein Cholesterol Level
Babaya et al.
J. Clin. Endocrinol. Metab. 2003;88:2548-2551.
ABSTRACT
| FULL TEXT
Osteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E-Deficient Mice
Matsui et al.
Arterioscler. Thromb. Vasc. Bio. 2003;23:1029-1034.
ABSTRACT
| FULL TEXT
Lipid-Lowering Therapy and Risk of Coronary Events
Lardinois
JAMA 2003;289:2071-2071.
FULL TEXT
Enhancement of Scavenger Receptor Class B Type I-mediated Selective Cholesteryl Ester Uptake from apoA-I-/- High Density Lipoprotein (HDL) by Apolipoprotein A-I Requires HDL Reorganization by Lecithin Cholesterol Acyltransferase
Temel et al.
J. Biol. Chem. 2003;278:4792-4799.
ABSTRACT
| FULL TEXT
Carbohydrate Intake Is Associated with Diet Quality and Risk Factors for Cardiovascular Disease in U.S. Adults: NHANES III
Yang et al.
J. Am. Coll. Nutr. 2003;22:71-79.
ABSTRACT
| FULL TEXT
Non-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes: The Strong Heart Study
Lu et al.
Diabetes Care 2003;26:16-23.
ABSTRACT
| FULL TEXT
Dietary and plasma lipid, lipoprotein, and apolipoprotein profiles among elderly Hispanics and non-Hispanics and their association with diabetes
Bermudez et al.
Am. J. Clin. Nutr. 2002;76:1214-1221.
ABSTRACT
| FULL TEXT
An Assessment of the Independent Effects of Olanzapine and Risperidone Exposure on the Risk of Hyperlipidemia in Schizophrenic Patients
Koro et al.
Arch Gen Psychiatry 2002;59:1021-1026.
ABSTRACT
| FULL TEXT
Nonfasting Apolipoprotein B and Triglyceride Levels as a Useful Predictor of Coronary Heart Disease Risk in Middle-Aged UK Men
Talmud et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:1918-1923.
ABSTRACT
| FULL TEXT
